The recent 3.5% gain must have brightened CEO Francesco Siccardi's week, Medacta Group SA's (VTX:MOVE) most bullish insider

Explore Medacta Group's Fair Values from the Community and select yours

Key Insights

Significant insider control over Medacta Group implies vested interests in company growth The top 3 shareholders own 60% of the company Institutional ownership in Medacta Group is 13%

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

A look at the shareholders of Medacta Group SA (VTX:MOVE) can tell us which group is most powerful. With 70% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, insiders scored the highest last week as the company hit CHF3.1b market cap following a 3.5% gain in the stock.

Let's take a closer look to see what the different types of shareholders can tell us about Medacta Group.

View our latest analysis for Medacta Group SWX:MOVE Ownership Breakdown August 13th 2025

What Does The Institutional Ownership Tell Us About Medacta Group?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Medacta Group. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Medacta Group's historic earnings and revenue below, but keep in mind there's always more to the story.SWX:MOVE Earnings and Revenue Growth August 13th 2025

We note that hedge funds don't have a meaningful investment in Medacta Group. The company's CEO Francesco Siccardi is the largest shareholder with 20% of shares outstanding. The second and third largest shareholders are Alessandro Siccardi and Maria Siccardi Tonolli, with an equal amount of shares to their name at 20%. Note that two of the top three shareholders are also Senior Key Executive and Member of the Board of Directors, respectively, once again pointing to significant ownership by company insiders.

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 60% stake.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Story Continues

Insider Ownership Of Medacta Group

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders own more than half of Medacta Group SA. This gives them effective control of the company. That means insiders have a very meaningful CHF2.2b stake in this CHF3.1b business. It is good to see this level of investment. You can check here to see if those insiders have been selling any of their shares.

General Public Ownership

The general public, who are usually individual investors, hold a 17% stake in Medacta Group. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Medacta Group , and understanding them should be part of your investment process.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this freereport on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments